Cascade testing for hereditary cancer syndromes: should we move toward direct relative contact? A systematic review and meta-analysis

MK Frey, MD Ahsan, H Bergeron, J Lin, X Li… - Journal of Clinical …, 2022 - ascopubs.org
PURPOSE Evidence-based guidelines recommend cascade genetic counseling and testing
for hereditary cancer syndromes, providing relatives the opportunity for early detection and …

Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care

GF Watts, SS Gidding, P Mata, J Pang… - Nature Reviews …, 2020 - nature.com
Optimal care for familial hypercholesterolaemia (FH) requires patient-centred management,
multidisciplinary teamwork, involvement of primary care practitioners, patient networks …

Comparison of universal genetic testing vs guideline-directed targeted testing for patients with hereditary cancer syndrome

NJ Samadder, D Riegert-Johnson, L Boardman… - JAMA …, 2021 - jamanetwork.com
Importance Hereditary factors play a key role in the risk of developing several cancers.
Identification of a germline predisposition can have important implications for treatment …

Barriers and facilitators for cascade testing in genetic conditions: a systematic review

S Srinivasan, NY Won, WD Dotson, ST Wright… - European Journal of …, 2020 - nature.com
Cascade testing is the process of offering genetic counseling and testing to at-risk relatives
of an individual who has been diagnosed with a genetic condition. It is critical for increasing …

Population genomic screening for three common hereditary conditions: a cost-effectiveness analysis

GF Guzauskas, S Garbett, Z Zhou… - Annals of Internal …, 2023 - acpjournals.org
Background: The cost-effectiveness of screening the US population for Centers for Disease
Control and Prevention (CDC) Tier 1 genomic conditions is unknown. Objective: To estimate …

Cost-effectiveness of population-wide genomic screening for hereditary breast and ovarian cancer in the United States

GF Guzauskas, S Garbett, Z Zhou, SJ Spencer… - JAMA network …, 2020 - jamanetwork.com
Importance Genomic screening for hereditary breast and ovarian cancer (HBOC) in
unselected women offers an opportunity to prevent cancer morbidity and mortality, but the …

Cascading after peridiagnostic cancer genetic testing: an alternative to population-based screening

K Offit, KA Tkachuk, ZK Stadler, MF Walsh… - Journal of Clinical …, 2020 - ascopubs.org
PURPOSE Despite advances in DNA sequencing technology and expanded medical
guidelines, the vast majority of individuals carrying pathogenic variants of common cancer …

Exome sequencing reveals a high prevalence of BRCA1 and BRCA2 founder variants in a diverse population-based biobank

NS Abul-Husn, ER Soper, JA Odgis, S Cullina… - Genome medicine, 2020 - Springer
Background Pathogenic variants in BRCA1 and BRCA2 (BRCA1/2) lead to increased risk of
breast, ovarian, and other cancers, but most variant-positive individuals in the general …

Use of a chatbot to increase uptake of cascade genetic testing

T Schmidlen, CL Jones… - Journal of genetic …, 2022 - Wiley Online Library
Successful proband‐mediated family communication and subsequent cascade genetic
testing uptake requires interventions that present information clearly, in sufficient detail, and …

Opportunities, resources, and techniques for implementing genomics in clinical care

TA Manolio, R Rowley, MS Williams, D Roden… - The Lancet, 2019 - thelancet.com
Advances in technologies for assessing genomic variation and an increasing understanding
of the effects of genomic variants on health and disease are driving the transition of …